News WrapGet Handpicked Stories from our editors directly to your mailbox

Sun Pharmaceutical

Sun Pharma arm to acquire shares of Israeli firm Tarsius Pharma for $3 million

Indicative time period for completion of the acquisition is before September 15, 2018, Sun Pharma said.

Sep 10, 2018, 17:25 PM IST

Sun Pharma Q1 net loss at Rs 424.92 crore

The company had posted a net profit after taxes, share of profit/loss of associates, joint ventures and non-controlling interests of Rs 2,033.71 crore for the same period a year ago, Sun Pharmaceutical Industries said in a filing to the BSE.

Aug 11, 2017, 16:38 PM IST

Sun Pharma gets warning letter from USFDA over Halol unit

Drug major Sun Pharmaceutical Industries on Saturday said it has received a warning letter from the USFDA over violation of manufacturing norms in its facility at Halol in Gujarat.

Dec 19, 2015, 14:37 PM IST

Sun Pharma Q2 net profit dips 46% to Rs 1,107 crore

Drug major Sun Pharmaceutical Industries on Saturday reported 46.02 percent dip in its consolidated net profit at Rs 1,106.66 crore for the second quarter ended September 30, 2015 on account of lower sales, volatile currency movements and supply constraints.

Nov 07, 2015, 18:12 PM IST

Sun Pharma withdraws suit filed by Ranbaxy against USFDA

The lawsuit challenged FDA's revocation of Ranbaxy's tentative approvals for its generic versions of Nexium and Valcyte in the US.

Oct 09, 2015, 14:54 PM IST

Sun Pharma shareholders approve amalgamation scheme

Sun Pharmaceutical on Friday said court convened meeting of its shareholders has approved the scheme of amalgamation of Sun Pharma Global Inc with itself.

Jun 05, 2015, 14:58 PM IST

Sun Pharma, AstraZeneca seal distribution deal

Drug majors Sun Pharmaceutical and AstraZeneca Pharma India (AZPIL) on Tuesday said they have entered into a distribution services agreement to distribute AstraZeneca's heart disease treatment drug 'Axcer' in India.

Jun 02, 2015, 12:32 PM IST

Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 billion on M&A: Bankers

Sun Pharma, which has a market value of nearly $36 billion, is also interested in non-biotech complex generic medicine.

Apr 28, 2015, 11:13 AM IST

Sun Pharma shares bounce back, up nearly 2% at close

Shares of Sun Pharmaceutical Wednesday recovered nearly 2 percent to close at Rs 967.15 on BSE a day after the stock took a severe beating following Daiichi Sankyo selling its entire 9 percent stake in the company for Rs 20,025 crore.

Apr 22, 2015, 19:21 PM IST

Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma

The company was clarifying on speculations that Sanghvi, who holds 9.61 percent stake in Sun Pharma, had bought shares when Daiichi Sankyo exited from the Indian firm.

Apr 22, 2015, 12:04 PM IST

Daiichi Sankyo exits Sun Pharma; ends 7 years of tumultuous ride in India

The company, which had forayed into the growing Indian pharmaceutical market by buying a majority stake in Ranbaxy Laboratories in 2008 for Rs 22,000 crore, sold over 21 crore shares in Sun Pharma.

Apr 21, 2015, 14:42 PM IST

Japan's Daiichi completely exits Sun Pharma

Yesterday, Daiichi Sankyo Company Ltd had announced its decision to sell "the entire or part of its holdings of Sun Pharmaceutical shares..."

Apr 21, 2015, 12:40 PM IST

Daiichi Sankyo to offload stake in Sun Pharma worth Rs 22,000 cr

Japanese drug maker Daiichi Sankyo Monday said it board has approved selling a part or entire 9 percent holding worth over Rs 22,000 crore in Indian drug major Sun Pharmaceutical.

Apr 20, 2015, 18:53 PM IST

Ranbaxy stock to stop trading on exchanges from next week

Shares of Ranbaxy Laboratories will stop trading on BSE and NSE with effect from April 6 onwards as the company is merging with Sun Pharmaceutical Industries in a USD 4 billion deal.

Apr 04, 2015, 23:15 PM IST

Ranbaxy ends last trading day on bright note; surges over 5%

Shares of Ranbaxy Laboratories on Wednesday ended with strong gains on the last day of its trade, as the company is being merged with Sun Pharmaceutical in a USD 4 billion deal.

Apr 01, 2015, 19:07 PM IST

HC allows merger of Ranbaxy and Sun pharma

The Punjab and Haryana High Court Monday gave its nod to the merger of two Indian pharmaceutical companies - Ranbaxy Laboratories Limited with Sun Pharmaceutical Industries Limited.

Mar 09, 2015, 23:00 PM IST

Dilip Shanghvi to buy equity worth Rs 1,800 crore in Suzlon

Wind turbine maker Suzlon Energy has signed definitive agreements with Dilip Shanghvi Family and Associates (DSA) for equity investments of Rs 1,800 crore.

Feb 14, 2015, 08:42 AM IST

Sun Pharma falls 6% on reports of FDA inspection at Halol unit

Sun Pharmaceutical Industries on Thursday slumped as much as 6 percent, heading towards its biggest single day fall since March 16, 2012.

Sep 11, 2014, 11:10 AM IST

Sun Pharma recalls 200 vials of cancer drug: FDA

Sun Pharmaceutical Industries Ltd is recalling 200 vials of the chemotherapy drug gemcitabine in the United States due to a lack of assurance of sterility, the U.S. Food and Drug Administration said on Thursday.

Jul 03, 2014, 13:22 PM IST

Ranbaxy Q4 net loss at Rs 73.6 cr

Drug major Ranbaxy Laboratories on Friday posted consolidated net loss of Rs 73.6 crore for the fourth quarter ended March 31, 2014

May 09, 2014, 16:24 PM IST